Document is current
Any future updates will be listed below
-
Authors
Wessels, Elise M. https://orcid.org/0000-0002-3721-8279
Masclee, Gwen M. C. https://orcid.org/0000-0002-2839-027X
Schuitenmaker, Jeroen M. https://orcid.org/0000-0002-1213-3551
Bredenoord, Albert J. https://orcid.org/0000-0001-5918-2062
- License Information
-
More Information
Article History
Received: 12 March 2026
Accepted: 6 April 2026
First Online: 15 April 2026
Declarations
:
: EMW, GMCM and JMS have nothing to declare. AJB received research funding from DrFalkPharma, Thelial, Sanofi/Regeneron and SST and received speaker and/or consulting fees from Laborie, Medtronic, BMS, Dr. Falk Pharma, Reckitt, Aqilion, Eupraxia, Uniquity, Alimentiv, Aquilion, Sanofi/Regeneron and AstraZeneca.
: Approval of the local Medical Ethics Committee Amsterdam Medical Centre (7 November 2019, 2019_220#B2019758). Study registration at the Dutch National Trial Register (NL8657).
: written informed consent was obtained from all patients.
